Cerevel Therapeutics Hldng I shares owned by Affinity Asset Advisors
Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Affinity Asset Advisors
from 13F filings
Historical chart of Affinity Asset Advisors investment in Cerevel Therapeutics Hldng I
Tip: Access up to 7 years of quarterly data
All positions including Cerevel Therapeutics Hldng I held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cerevel Therapeutics Hldng I by Affinity Asset Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $15M | 685k | 21.83 |
| 2023-06-30 | $18M | 550k | 31.79 |
| 2023-03-31 | $9.3M | 380k | 24.39 |
| 2022-12-31 | $6.8M | 215k | 31.54 |
| 2022-03-31 | $2.5M | 70k | 35.01 |
| 2021-12-31 | $7.3M | 225k | 32.42 |
| 2021-09-30 | $7.7M | 260k | 29.50 |
| 2021-06-30 | $5.1M | 200k | 25.62 |
| 2021-03-31 | $3.7M | 270k | 13.73 |
| 2020-12-31 | $4.5M | 270k | 16.58 |